NO20043377L - R-(-)-1-[2-(7-klorbenzo[b]tiofen-3-yl-metoksy)-2-(2,4-diklorfenyl)-etyl]-1H-imidazol - Google Patents

R-(-)-1-[2-(7-klorbenzo[b]tiofen-3-yl-metoksy)-2-(2,4-diklorfenyl)-etyl]-1H-imidazol

Info

Publication number: NO20043377L
Authority: NO; Norway
Prior art keywords: thiophen; imidazole; methoxy; ethyl; dichlorophenyl
Prior art date: 2002-02-11

Application number

NO20043377A

Other languages

English (en)

Other versions

NO327937B1 (no

Inventor

Rafael Foguet

Jorge Ramentol

Antonio Guglietta

Celia Palacin

Luis Anglada

Original Assignee

Ferrer Int

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2002-02-11

Filing date

2004-08-13

Publication date

2004-08-13

2004-08-13 Application filed by Ferrer Int filed Critical Ferrer Int

2004-08-13 Publication of NO20043377L publication Critical patent/NO20043377L/no

2009-10-26 Publication of NO327937B1 publication Critical patent/NO327937B1/no

Links

JLGKQTAYUIMGRK-IBGZPJMESA-N arasertaconazole Chemical compound ClC1=CC(Cl)=CC=C1[C@@H](OCC=1C2=CC=CC(Cl)=C2SC=1)CN1C=NC=C1 JLGKQTAYUIMGRK-IBGZPJMESA-N 0.000 title abstract 2
206010017533 Fungal infection Diseases 0.000 abstract 1
241001465754 Metazoa Species 0.000 abstract 1
208000031888 Mycoses Diseases 0.000 abstract 1
201000010099 disease Diseases 0.000 abstract 1
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
239000000203 mixture Substances 0.000 abstract 1
150000003839 salts Chemical class 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Life Sciences & Earth Sciences (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Communicable Diseases (AREA)
Pharmacology & Pharmacy (AREA)
Oncology (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)
Agricultural Chemicals And Associated Chemicals (AREA)

NO20043377A 2002-02-11 2004-08-13 R-(-)-1-[2-(7-klorbenzo[b]tiofen-3-yl-metoksy)-2-(2,4-diklorfenyl)-etyl]-1H-imidazol, fremgangsmate for fremstilling derav, preparat derav, samt anvendelse derav for behandling av soppinfeksjoner hos mennesker eller dyr, og bekjempelse av avlingssykdommer NO327937B1 (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
ES200200328A ES2203316B1 (es)	2002-02-11	2002-02-11	R-(-)-1-(2-(7-cloro-benzo(b)tiofen-3-il-metoxi)-2-(2,4-dicloro-fenil)-etil)1h-imidazol.
PCT/EP2003/001089 WO2003068770A1 (en)	2002-02-11	2003-02-04	R- (-) -1- [2- (7-CHLOROBENZO [b] THIOPHEN-3 -YL- METHOXY) -2- (2,4-DICHLOROPHENYL) -ETHYL] -1H-IMIDAZOLE

Publications (2)

Publication Number	Publication Date
NO20043377L true NO20043377L (no)	2004-08-13
NO327937B1 NO327937B1 (no)	2009-10-26

Family

ID=27675919

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20043377A NO327937B1 (no)	2002-02-11	2004-08-13	R-(-)-1-[2-(7-klorbenzo[b]tiofen-3-yl-metoksy)-2-(2,4-diklorfenyl)-etyl]-1H-imidazol, fremgangsmate for fremstilling derav, preparat derav, samt anvendelse derav for behandling av soppinfeksjoner hos mennesker eller dyr, og bekjempelse av avlingssykdommer

Country Status (24)

Country	Link
US (1)	US7323433B2 (no)
EP (1)	EP1474422B1 (no)
JP (1)	JP5095070B2 (no)
KR (1)	KR100701457B1 (no)
CN (1)	CN1315824C (no)
AT (1)	ATE382618T1 (no)
AU (1)	AU2003205733B8 (no)
BR (1)	BR0307754A (no)
CA (1)	CA2474627C (no)
CO (1)	CO5601026A2 (no)
DE (1)	DE60318395T2 (no)
DK (1)	DK1474422T3 (no)
ES (1)	ES2203316B1 (no)
IL (1)	IL163452A (no)
MX (1)	MXPA04007581A (no)
NO (1)	NO327937B1 (no)
NZ (1)	NZ534464A (no)
PL (1)	PL211168B1 (no)
PT (1)	PT1474422E (no)
RU (1)	RU2276152C1 (no)
TN (1)	TNSN04140A1 (no)
UA (1)	UA78010C2 (no)
WO (1)	WO2003068770A1 (no)
ZA (1)	ZA200405941B (no)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ES2249991B1 (es) *	2004-09-13	2007-03-01	Ferrer Internacional, S.A.	Procedimiento de fabricacion de compuestos imidazolicos, sus sales y sus pseudopolimorfos.
ES2249992B1 (es) *	2004-09-13	2007-03-01	Ferrer Internacional, S.A.	Un procedimiento para fabricar compuestos enantiomericos del imidazol.
EP1698336A1 (en) *	2005-03-01	2006-09-06	Ferrer Internacional, S.A.	Antifungal compositions comprising Sertaconazole and either Hydrocortisone or an antibacterial agent
MX2011006002A (es) *	2008-12-09	2011-06-20	Ferrer Int	Polimorfo ii de un compuesto antifungico.
EP2436374A1 (en) *	2010-09-30	2012-04-04	Ferrer Internacional, S.A.	Ovule for vaginal administration of arasertaconazole
EP2551351A1 (en)	2011-07-29	2013-01-30	Interquim, S.A.	Process for production of optically active (R)-(-)-1-(2,4-dichloro-phenyl)-2-imidazole-1-yl-ethanol
CN102440947B (zh) *	2011-11-15	2012-12-26	海南海神同洲制药有限公司	硝酸舍他康唑乳膏剂
KR101717968B1 (ko)	2016-07-18	2017-03-20	씨앤아이 주식회사	스마트폰 결합 모듈
CN113480517B (zh) *	2021-07-30	2022-09-09	海南海神同洲制药有限公司	3-溴甲基-7-氯苯并[b]噻吩的合成方法
CN113735843B (zh) *	2021-09-07	2023-05-26	海南海神同洲制药有限公司	一种低熔点硝酸舍他康唑的制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB1475271A (en) *	1975-04-30	1977-06-01	Pfizer Ltd	1-aryl-2-1-imidazolyl-alkyl ethers and thioethers and their use as antifungal agents
US5135943A (en) *	1984-02-02	1992-08-04	Ferrer Internacional S.A.	1H-imidazole derivative compounds and pharmaceutical compositions containing the same
CA1250586A (en) *	1984-02-02	1989-02-28	Manuel Raga	1h-imidazole derivatives and process for their production
US5087620A (en) *	1990-05-17	1992-02-11	Bristol-Myers Squibb Co.	Controlled dermal penetration enhancement using imidazoles
KR100336642B1 (ko) *	1995-01-04	2002-11-23	페레르 인터내쇼날 에스.에이.	1-[2,4-디클로로-β-[7-클로로벤조[B]티엔-3-일)메톡시]페네틸]이미다졸모노나이트레이트의폴리모르프B및C의제조방법

2002
- 2002-02-11 ES ES200200328A patent/ES2203316B1/es not_active Expired - Fee Related
2003
- 2003-02-04 AT AT03702597T patent/ATE382618T1/de active
- 2003-02-04 NZ NZ534464A patent/NZ534464A/en not_active IP Right Cessation
- 2003-02-04 RU RU2004127573/04A patent/RU2276152C1/ru not_active IP Right Cessation
- 2003-02-04 CN CNB038036592A patent/CN1315824C/zh not_active Expired - Fee Related
- 2003-02-04 BR BR0307754-3A patent/BR0307754A/pt not_active IP Right Cessation
- 2003-02-04 MX MXPA04007581A patent/MXPA04007581A/es active IP Right Grant
- 2003-02-04 JP JP2003567897A patent/JP5095070B2/ja not_active Expired - Fee Related
- 2003-02-04 DE DE60318395T patent/DE60318395T2/de not_active Expired - Lifetime
- 2003-02-04 WO PCT/EP2003/001089 patent/WO2003068770A1/en not_active Ceased
- 2003-02-04 PL PL370251A patent/PL211168B1/pl unknown
- 2003-02-04 EP EP03702597A patent/EP1474422B1/en not_active Expired - Lifetime
- 2003-02-04 PT PT03702597T patent/PT1474422E/pt unknown
- 2003-02-04 KR KR1020047012352A patent/KR100701457B1/ko not_active Expired - Fee Related
- 2003-02-04 DK DK03702597T patent/DK1474422T3/da active
- 2003-02-04 AU AU2003205733A patent/AU2003205733B8/en not_active Ceased
- 2003-02-04 CA CA002474627A patent/CA2474627C/en not_active Expired - Fee Related
- 2003-04-02 UA UA20040806675A patent/UA78010C2/uk unknown
2004
- 2004-07-26 ZA ZA200405941A patent/ZA200405941B/en unknown
- 2004-07-29 TN TNP2004000140A patent/TNSN04140A1/en unknown
- 2004-08-05 US US10/911,572 patent/US7323433B2/en not_active Expired - Fee Related
- 2004-08-06 CO CO04076775A patent/CO5601026A2/es not_active Application Discontinuation
- 2004-08-10 IL IL163452A patent/IL163452A/en not_active IP Right Cessation
- 2004-08-13 NO NO20043377A patent/NO327937B1/no not_active IP Right Cessation

Also Published As

Publication number	Publication date
JP5095070B2 (ja)	2012-12-12
NZ534464A (en)	2006-02-24
JP2005524639A (ja)	2005-08-18
EP1474422B1 (en)	2008-01-02
TNSN04140A1 (en)	2007-03-12
ES2203316A1 (es)	2004-04-01
CN1315824C (zh)	2007-05-16
AU2003205733B8 (en)	2008-09-04
MXPA04007581A (es)	2004-11-10
CA2474627C (en)	2009-09-22
US7323433B2 (en)	2008-01-29
NO327937B1 (no)	2009-10-26
UA78010C2 (uk)	2007-02-15
KR20040079996A (ko)	2004-09-16
ATE382618T1 (de)	2008-01-15
BR0307754A (pt)	2004-12-07
DE60318395D1 (de)	2008-02-14
CA2474627A1 (en)	2003-08-21
IL163452A (en)	2011-11-30
AU2003205733A1 (en)	2003-09-04
DK1474422T3 (da)	2008-05-13
ES2203316B1 (es)	2005-03-01
CO5601026A2 (es)	2006-01-31
PT1474422E (pt)	2008-02-28
PL211168B1 (pl)	2012-04-30
CN1630654A (zh)	2005-06-22
AU2003205733B2 (en)	2008-08-14
HK1070883A1 (en)	2005-06-30
PL370251A1 (en)	2005-05-16
EP1474422A1 (en)	2004-11-10
KR100701457B1 (ko)	2007-03-29
RU2004127573A (ru)	2006-02-10
US20050065201A1 (en)	2005-03-24
DE60318395T2 (de)	2009-01-02
RU2276152C1 (ru)	2006-05-10
ZA200405941B (en)	2006-07-26
WO2003068770A1 (en)	2003-08-21

Legal Events

Date	Code	Title	Description
2017-09-25	MM1K	Lapsed by not paying the annual fees

Publication	Publication Date	Title
FR2836915B1 (fr)	2008-01-11	Derives d'aminoindazoles, procede de preparation et intermediaires de ce procede a titre de medicaments et compositions pharmaceutiques les renfermant
WO2005030753A3 (en)	2005-05-06	Therapeutic agents useful for treating pain
MY125356A (en)	2006-07-31	Moxifloxacin/sodium chloride formulation
WO2004029031A3 (en)	2004-08-05	Therapeutic piperazine compounds
WO2004016086A3 (en)	2004-04-29	2,4,5-trisubstituted imidazoles and their use as anti-microbial agents
SE9900961D0 (sv)	1999-03-16	Novel compounds
NO20043377L (no)	2004-08-13	R-(-)-1-[2-(7-klorbenzo[b]tiofen-3-yl-metoksy)-2-(2,4-diklorfenyl)-etyl]-1H-imidazol
IS2613B (is)	2010-04-15	Útskipt díketópíperasín sem oxýtósínblokkar
EA200100653A1 (ru)	2001-12-24	Способ борьбы с членистоногими у животных
MY136449A (en)	2008-10-31	N-(3-methoxy-5-methylpyrazin-2-yl)-2-(4-[1,3,4-oxadiazol-2-yl]phenyl)pyridine-3-sulphonamide for the treatment of cancer
ATE260559T1 (de)	2004-03-15	Sordarinderivate
BG104259A (bg)	2000-12-29	Производни на 4-циано-4-деформилсордарицин
WO2003007878A3 (en)	2004-04-22	Antifungal agents of sordarin derivatives
BRPI0414319A (pt)	2006-11-07	agentes antibacterianos de quinolona
ATE241979T1 (de)	2003-06-15	4-cyano-4-deformylsordarinderivate
CR7413A (es)	2005-02-10	R-(-)-1-[2-(7-Chlorobenzo[b]thiophen-3-yl-methozy)-2-(2,4-dichlorophenyl)-ethyl]-1H-imidazole
MXPA05013760A (es)	2006-03-08	Composicion y procedimiento de tratamiento del platanero y del bananero.
UA49382A (uk)	2002-09-16	Спосіб лікування дерматозів
ITMI20030430V0 (it)	2003-09-23	Catetere perfezionato per l'inseminazione artificiale di conigli